Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model

A cutaneous melanoma mouse model was used to test the efficacy of a new therapeutical approach that uses low doses of cytostatics in conjunction with mild whole body microwave exposure of 2.45 GHz in order to enhance cytostatics antitumoral effect. Materials and Methods. A microwave exposure system...

Full description

Saved in:
Bibliographic Details
Main Authors: Monica Neagu, Carolina Constantin, Diana Martin, Lucian Albulescu, Nicusor Iacob, Daniel Ighigeanu
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Radiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/414816
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850158363944419328
author Monica Neagu
Carolina Constantin
Diana Martin
Lucian Albulescu
Nicusor Iacob
Daniel Ighigeanu
author_facet Monica Neagu
Carolina Constantin
Diana Martin
Lucian Albulescu
Nicusor Iacob
Daniel Ighigeanu
author_sort Monica Neagu
collection DOAJ
description A cutaneous melanoma mouse model was used to test the efficacy of a new therapeutical approach that uses low doses of cytostatics in conjunction with mild whole body microwave exposure of 2.45 GHz in order to enhance cytostatics antitumoral effect. Materials and Methods. A microwave exposure system for C57BL/6 mouse whole body microwave irradiation was designed; groups of 40 mice (males and females) bearing experimental tumours were subjected to a combined therapy comprising low doses of dacarbazine in combination with mild whole body irradiation. Clinical parameters and serum cytokine testing using xMAP technology were performed. Results. The group that was subjected to combined therapy, microwave and cytostatic, had the best clinical evolution in terms of overall survival, tumour volume, and metastatic potential. At day 14 the untreated group had 100% mortality, while in the combined therapy group 40% of mice were surviving. Quantifying serum IL-1β, IL-6, IL-10, IL-12 (p70), IFN-γ, GM-CSF, TNF-α, MIP-1α, MCP-1, and KC during tumorigenesis and therapy found that the combined experimental therapy decreases all the inflammatory cytokines, except chemokine MCP-1 that was found increased, suggesting an increase of the anti-tumoral immune response triggered by the combined therapy. The overall metastatic process is decreased in the combined therapy group.
format Article
id doaj-art-63e67273bde642ea9616b0bf10adf2ee
institution OA Journals
issn 2090-1941
2090-195X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Radiology Research and Practice
spelling doaj-art-63e67273bde642ea9616b0bf10adf2ee2025-08-20T02:23:53ZengWileyRadiology Research and Practice2090-19412090-195X2013-01-01201310.1155/2013/414816414816Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse ModelMonica Neagu0Carolina Constantin1Diana Martin2Lucian Albulescu3Nicusor Iacob4Daniel Ighigeanu5Immunology Department, Immunobiology Laboratory, “Victor Babes” National Institute of Pathology, 99-101 Splaiul Independentei, sector 5, Bucharest 050096, RomaniaImmunology Department, Immunobiology Laboratory, “Victor Babes” National Institute of Pathology, 99-101 Splaiul Independentei, sector 5, Bucharest 050096, RomaniaNational Institute for Laser, Plasma and Radiation Physics, 409 Atomistilor Street, Magurele 077125, RomaniaDepartment of Infectious Diseases and Immunology, Virology Division, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The NetherlandsNational Institute for Laser, Plasma and Radiation Physics, 409 Atomistilor Street, Magurele 077125, RomaniaNational Institute for Laser, Plasma and Radiation Physics, 409 Atomistilor Street, Magurele 077125, RomaniaA cutaneous melanoma mouse model was used to test the efficacy of a new therapeutical approach that uses low doses of cytostatics in conjunction with mild whole body microwave exposure of 2.45 GHz in order to enhance cytostatics antitumoral effect. Materials and Methods. A microwave exposure system for C57BL/6 mouse whole body microwave irradiation was designed; groups of 40 mice (males and females) bearing experimental tumours were subjected to a combined therapy comprising low doses of dacarbazine in combination with mild whole body irradiation. Clinical parameters and serum cytokine testing using xMAP technology were performed. Results. The group that was subjected to combined therapy, microwave and cytostatic, had the best clinical evolution in terms of overall survival, tumour volume, and metastatic potential. At day 14 the untreated group had 100% mortality, while in the combined therapy group 40% of mice were surviving. Quantifying serum IL-1β, IL-6, IL-10, IL-12 (p70), IFN-γ, GM-CSF, TNF-α, MIP-1α, MCP-1, and KC during tumorigenesis and therapy found that the combined experimental therapy decreases all the inflammatory cytokines, except chemokine MCP-1 that was found increased, suggesting an increase of the anti-tumoral immune response triggered by the combined therapy. The overall metastatic process is decreased in the combined therapy group.http://dx.doi.org/10.1155/2013/414816
spellingShingle Monica Neagu
Carolina Constantin
Diana Martin
Lucian Albulescu
Nicusor Iacob
Daniel Ighigeanu
Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
Radiology Research and Practice
title Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
title_full Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
title_fullStr Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
title_full_unstemmed Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
title_short Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model
title_sort whole body microwave irradiation for improved dacarbazine therapeutical action in cutaneous melanoma mouse model
url http://dx.doi.org/10.1155/2013/414816
work_keys_str_mv AT monicaneagu wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel
AT carolinaconstantin wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel
AT dianamartin wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel
AT lucianalbulescu wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel
AT nicusoriacob wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel
AT danielighigeanu wholebodymicrowaveirradiationforimproveddacarbazinetherapeuticalactionincutaneousmelanomamousemodel